Project Grant HT9425261E174
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $700K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency awarded UCLA a $350,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2026, for the development of a polylactic acid (PLA)-based, immunohistochemistry (IHC)-compatible functional assay designed to detect homologous recombination deficiency in ovarian cancer. The research will be conducted at UCLA's Los Angeles campus through September 29, 2028. This award supports the Defense Health...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles (UCLA) a $2.076 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2026 through August 31, 2030. The award supports research to define an error-free DNA repair signature as a predictive marker for lethal prostate cancer. This research initiative aligns with the DHA's mission to transform healthcare for military...
- Federal Grant Award Summary The University of California, Los Angeles (UCLA) received a $799,999 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026, through April 30, 2030. The project, titled "From H&E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction," involves the development of integrated analytical methodologies and data systems that combine...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $235,476 project grant to the University of California, Los Angeles (UCLA) Office of Research Administration on November 1, 2025, to develop new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The two-year award, which concludes October 31, 2027, is funded under the Military Medical Research and Development program (CFDA 12.420) and will be conducted at UCLA's Los Angeles, California facility....
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $2.16M Project Grant on September 30, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on cerebellar neuromodulation to reduce cognitive dysfunction after multiple subconcussive impacts. The four-year project, scheduled for completion on September 29, 2029, will be performed at UCLA's Los Angeles campus through the Office of Research Administration. This award supports...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded University of California, Los Angeles (UCLA) a $1.7 million project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct functional evaluation and optimization of chimeric antigen receptor T (CAR-T) cells targeting prostate cancer. The three-year award, effective July 1, 2026 through June 30, 2029, funds research utilizing engineered nanovials to conduct cell-cell interaction...
- Federal Project Grant Award Summary The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded a $157,500 Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration, effective September 1, 2025, with completion scheduled for August 31, 2026. The award supports research investigating the impact of a hypomorphic SMARCB1 germline allele specific for schwannomatosis on mouse development and...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles (UCLA) a $1,499,881 project grant effective July 1, 2026 through June 30, 2030 under the Military Medical Research and Development program (CFDA 12.420). UCLA will develop a personalized and actionable brain health prediction algorithm designed to support post-9/11 service members and veterans. The research initiative, conducted at UCLA's Los Angeles campus through the Office...
- Federal Project Grant Summary The Defense Health Agency awarded a $590,625 Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration on September 1, 2025, under the Military Medical Research and Development program (CFDA 12.420). The three-year research initiative, concluding August 31, 2028, supports a pilot study investigating dual immunotherapy combining PD-1 and CD73 checkpoint inhibitors with chemotherapy in patients with pancreatic...